HGN halcygen pharmaceuticals limited

halcygen announcement

  1. 49 Posts.
    HALCYGEN FILES IND WITH THE US FDA TO BEGIN CLINICAL
    DEVELOPMENT AND REGISTRATION OF SUBAITRACONAZOLETM
    Improved anti-fungal targeting $600m market.announcement is worth a read
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.